Loading clinical trials...
Loading clinical trials...
Age-related macular degeneration (AMD) is the leading cause of severe and irreversible visual loss and classified blindness in the elderly throughout Europe and the US. Among these patients, about 6%-...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medical University of Vienna
NCT06943599 · Age Related Macular Degeneration, Diabetic Retinopathy, and more
NCT07249216 · Age Related Macular Degeneration
NCT06694272 · Age Related Macular Degeneration
NCT06787482 · Retinitis Pigmentosa (RP), Age Related Macular Degeneration, and more
NCT04697095 · Age Related Macular Degeneration
Medical University of Vienna
Vienna
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions